| ASSET | YEAR | % RETURN |
|---|---|---|
Cato (CATO) | 1991 | 1,916.65% |
Envela (ELA) | 1991 | 990.91% |
Biomerica (BMRA) | 1991 | 897.34% |
BioLife Solutions (BLFS) | 1991 | 765.98% |
Magna International (MGA) | 1991 | 610.48% |
Jack Henry & Associates (JKHY) | 1991 | 572.97% |
Oppenheimer (OPY) | 1991 | 478.94% |
Brightstar Lottery (BRSL) | 1991 | 441.01% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Gencor Industries (GENC) | 1991 | 411.21% |
CEL-SCI (CVM) | 1991 | 410% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Mesa Laboratories (MLAB) | 1991 | 383.33% |
National HealthCare (NHC) | 1991 | 335.93% |
Toll Brothers (TOL) | 1991 | 328.57% |
Veru (VERU) | 1991 | 325.4% |
Bio-Techne (TECH) | 1991 | 308.1% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Electronic Arts (EA) | 1991 | 302.67% |
Educational Development (EDUC) | 1991 | 299.7% |
Charles Schwab (SCHW) | 1991 | 299.65% |
Plexus (PLXS) | 1991 | 289.75% |
Griffon (GFF) | 1991 | 283.36% |
Merit Medical Systems (MMSI) | 1991 | 274.31% |
